[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@LTbioinvestor](/creator/twitter/LTbioinvestor) "nice day for $RAPT have position since single digit @jfais20" [X Link](https://x.com/LTbioinvestor/status/1980283083338223945) [@LTbioinvestor](/creator/x/LTbioinvestor) 2025-10-20T14:40Z 17.1K followers, 3197 engagements "super high beta stocks decent pullback before next leg up imho $OKLO $IREN $NVTS $NTLA $RR $CIFR $PRME $ASTS . etc" [X Link](https://x.com/LTbioinvestor/status/1980718774597874082) [@LTbioinvestor](/creator/x/LTbioinvestor) 2025-10-21T19:32Z 17.1K followers, 1851 engagements "from last $BIOA ER : "The Company continued to advance its multi-year research collaboration with NOVARTIS announced in December 2024 focused on discovering novel therapeutic targets at the intersection of aging biology and exercise physiology with multiple targets under evaluation. BioAge progressed its strategic collaboration with LILLY ExploR&D announced in January 2025 for the development of therapeutic antibodies targeting novel metabolic aging targets identified through BioAge's discovery platform"" [X Link](https://x.com/LTbioinvestor/status/1981374369768054987) [@LTbioinvestor](/creator/x/LTbioinvestor) 2025-10-23T14:57Z 17.1K followers, 1456 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@LTbioinvestor
"nice day for $RAPT have position since single digit @jfais20"
X Link @LTbioinvestor 2025-10-20T14:40Z 17.1K followers, 3197 engagements
"super high beta stocks decent pullback before next leg up imho $OKLO $IREN $NVTS $NTLA $RR $CIFR $PRME $ASTS . etc"
X Link @LTbioinvestor 2025-10-21T19:32Z 17.1K followers, 1851 engagements
"from last $BIOA ER : "The Company continued to advance its multi-year research collaboration with NOVARTIS announced in December 2024 focused on discovering novel therapeutic targets at the intersection of aging biology and exercise physiology with multiple targets under evaluation. BioAge progressed its strategic collaboration with LILLY ExploR&D announced in January 2025 for the development of therapeutic antibodies targeting novel metabolic aging targets identified through BioAge's discovery platform""
X Link @LTbioinvestor 2025-10-23T14:57Z 17.1K followers, 1456 engagements
/creator/twitter::229966745/posts